Clinical trial

Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome

NCT05198362

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2021-12-28

PhasePHASE2

Study timeline

Study start (actual)2021-12-28Date precision: day

Registry last updated2022-12-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prader-Willi Syndromeunresolved

Interventions

PlaceboOTHER

TesometDRUG

Sponsors & collaborators

Sanionalead sponsor

Mapped research locations

LansingMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05198362 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.